SFN has been shown to increase the expression of tyrosine hydroxylase (TH) in the substantia nigra [71] and ventral midbrain [254] of 6-OHDA and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) models of PD, respectively. Here, TH is linked to Parkinson disease.